AqueSys, Inc.: Clinical Trials

3 trials sponsored by AqueSys, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 1 Not applicable, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 31Completed 1
Phase 41Completed 1

Follow AqueSys, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) Participants
XEN® Gel Stent, Cataract Surgery - Primary Open Angle Glaucoma
Phase 4CompletedAqueSys, Inc.1992013-12-052019-04-22
AqueSys XEN 45 Glaucoma Implant in Refractory Glaucoma
AqueSys XEN 45 Glaucoma Implant - Glaucoma, Glaucoma, Open Angle
Not applicableCompletedAqueSys, Inc.652013-01-012017-06-01
AqueSys Microfistula Implant in Refractory Glaucoma
AqueSys Microfistula Implant - Glaucoma, Glaucoma, Open-Angle
Phase 3CompletedAqueSys, Inc.602012-07-012016-02-08

Conditions studied

Glaucoma, Open-Angle (3)  ·  Glaucoma (2)  ·  Exfoliation Syndrome (1)

Interventions

Cataract Extraction (1)

Countries

United States (2)  ·  Austria (1)  ·  Belgium (1)  ·  Germany (1)  ·  Italy (1)  ·  Poland (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)  ·  Venezuela (1)

Top investigators

Richard A Lewis, M.D. (2)  ·  Vanessa Vera, MD (1)

Results publications

PMID 29267575, PMID 30758653